Multi-Omics And Mendelian Randomization Uncover Microbial-Metabolite-Gene Interactions In Age-Related Hearing Loss
Age-related hearing loss is a common condition among older adults, and its causes are complex, making effective treatments challenging. Recent research has taken a comprehensive approach, combining various types of biological data, a method known as “multi-omics,” to shed light on this intricate problem. This involves looking at genes, proteins, metabolites (small molecules involved in metabolism), and even the microbes living in our gut.
Through this integrated analysis, scientists identified 38 genes that appear to be central to age-related hearing loss. These genes are primarily involved in crucial biological processes such as NF-κB signaling (a pathway that controls inflammation), antigen presentation (how immune cells recognize threats), and oxidative phosphorylation (the process cells use to create energy). These findings suggest that metabolic imbalances and a state of “inflammatory aging” within the inner ear might contribute to hearing loss.
The study also employed a technique called Mendelian randomization, which uses genetic variations as natural experiments to determine if there’s a causal link between certain factors and a disease. This analysis highlighted three specific genes—UROS, C1QB, and GLIPR1—as potential biomarkers, meaning they could serve as indicators with high predictive value for age-related hearing loss. Further investigation revealed that GLIPR1 is associated with the presence of certain immune cells, specifically Th2 cells and neutrophils, suggesting an immune system involvement.
Intriguingly, the researchers found that another gene, FPR2, is significantly co-expressed with GLIPR1. Using computational methods like molecular docking and molecular dynamics simulations, which predict how molecules interact, they discovered that FPR2 can bind stably to taurodeoxycholic acid, a type of bile acid produced in the gut. Based on these connections, the study proposes a novel “Roseburia-FPR2-taurodeoxycholic acid” regulatory network. Roseburia is a type of gut bacteria, suggesting a potential link between our gut microbiome, specific metabolites, and genes in the development of age-related hearing loss.
This speculative model offers a new framework for future research into the “gut-inner ear axis,” exploring how the health and composition of our gut microbiota might influence the health of our hearing. Understanding these complex interactions could pave the way for new diagnostic tools and targeted interventions for age-related hearing loss.
Source: link to paper